SLC1A5 and breast cancer: Therefore, the aim of this study was to assess SLC1A5 gene copy number and its expression at both the mRNA and protein levels in large and well-characterised annotated cohorts of BC patients combined with in vitro approaches to determine its biological, clinicopathological and prognostic value in different molecular classes, with particular interest in highly proliferative aggressive subgroups.